Start up. Grow up. Succeed.

News 2010

Hepa Wash GmbH ranks 4th place in European Venture Contest final

Hepa Wash GmbH has ranked 4th place in the category “life sciences” in this years’ Eurecan European Venture Contest (EEVC) finale which

SuppreMol GmbH closes EUR 15.5 M Series C Financing Round

SuppreMol GmbH, a privately held biopharmaceutical company developing innovative therapeutics for the treatment of autoimmune diseases, today announced the closing of a EUR 15.5 million Series C financing round.

Pieris AG Signs Broad Collaboration with Sanofi-Aventis and Sanofi Pasteur to Develop Anticalin Therapeutics

Pieris AG announced today the signature of a collaboration and license agreement with both Sanofi-Aventis and Sanofi Pasteur, the vaccines division of the sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), under which Pieris will apply its proprietary Anticalin technology to discover novel Anticalin drugs against multiple targets, with further development undertaken by Sanofi-Aventis and Sanofi-Pasteur.

Federal Institute for Drugs and Medical Devices approves two clinical trials to evaluate the Hepa Wash liver dialysis device

The German Federal Institute for Drugs and Medical devices (BfArM) authorized the start of two clinical trials for a liver support therapy developed by the Munich-based medical device company Hepa Wash GmbH. The approval process examined the technical requirements as well as the plausibility of the study design. In March, Hepa Wash already received the required favorable opinion of the Ethics Committee of the hospital rechts der Isar of the Munich Technical University.

Hepa Wash GmbH climbs next level of the Eurecan European Venture Contest

Second success in front of international jury within weeks. Hepa Wash GmbH is one of the semi-final winners of this year’s Eurecan European Venture Contest (EEVC). The Munich medical device company competed with over 1.000 entrepreneurs from the innovation sectors of ICT,

Pieris AG Appoints a New CEO

Appointment will bring substantial deal-making expertise to the company. Pieris AG today announced the appointment of Stephen S. Yoder as CEO with immediate effect. Mr. Yoder takes over the position from interim CEO and co-founder Claus Schalper, who will remain CFO.